Copyright Reports & Markets. All rights reserved.

Global Drugs For Herpes Labialis (Oral Herpes) Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Valacyclovir
        • 1.2.1.2 Aciclovir
        • 1.2.1.3 Famciclovir
        • 1.2.1.4 Docosanol
        • 1.2.1.5 Others
      • 1.2.2 by Application
        • 1.2.2.1 External Use
        • 1.2.2.2 Oral
        • 1.2.2.3 Injection
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Valacyclovir Market, 2013-2018
      • 4.1.2 Aciclovir Market, 2013-2018
      • 4.1.3 Famciclovir Market, 2013-2018
      • 4.1.4 Docosanol Market, 2013-2018
      • 4.1.5 Others Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Valacyclovir Market Forecast, 2019-2024
      • 4.2.2 Aciclovir Market Forecast, 2019-2024
      • 4.2.3 Famciclovir Market Forecast, 2019-2024
      • 4.2.4 Docosanol Market Forecast, 2019-2024
      • 4.2.5 Others Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 External Use Market, 2013-2018
      • 5.1.2 Oral Market, 2013-2018
      • 5.1.3 Injection Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 External Use Market Forecast, 2019-2024
      • 5.2.2 Oral Market Forecast, 2019-2024
      • 5.2.3 Injection Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 GSK
    • 8.2 Novartis
    • 8.3 Teva
    • 8.4 Mylan
    • 8.5 Cadila
    • 8.6 Apotex
    • 8.7 Daewoong Pharmaceutical
    • 8.8 Livzon
    • 8.9 Luoxin
    • 8.10 Med shine
    • 8.11 Bayer (Campho Phenique)
    • 8.12 Blistex
    • 8.13 Kelun Group
    • 8.14 Hikma
    • 8.15 Haiwang
    • 8.16 Carmex
    • 8.17 Cipher

    9 Conclusion

    Summary
    Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
    The global Drugs For Herpes Labialis (Oral Herpes) market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Valacyclovir
    Aciclovir
    Famciclovir
    Docosanol
    Others
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    GSK
    Novartis
    Teva
    Mylan
    Cadila
    Apotex
    Daewoong Pharmaceutical
    Livzon
    Luoxin
    Med shine
    Bayer (Campho Phenique)
    Blistex
    Kelun Group
    Hikma
    Haiwang
    Carmex
    Cipher
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    External Use
    Oral
    Injection
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now